In Utero Exposure to DES or BPA increases EZH2 Expression in the Mammary Gland #EDCs #BreastCancer

Abstract:

In utero exposure to diethylstilbestrol (DES) or bisphenol-A (BPA) increases EZH2 expression in the mammary gland: an epigenetic mechanism linking endocrine disruptors to breast cancer

DES and BPA are estrogen-like endocrine-disrupting chemicals that induce persistent epigenetic changes in the developing uterus.

Diethylstilbestrol (DES) and Bisphenol-A (BPA) are estrogen-like endocrine-disrupting chemicals that induce persistent epigenetic changes in the developing uterus. However, DES exposure in utero is also associated with an increased risk of breast cancer in adult women. Similarly, fetal exposure to BPA induces neoplastic changes in mammary tissue of mice. We hypothesized that epigenetic alterations would precede the increased risk of breast neoplasia after in utero exposure to endocrine disruptors. Enhancer of Zeste Homolog 2 (EZH2) is a histone methyltransferase that has been linked to breast cancer risk and epigenetic regulation of tumorigenesis. We examined the effect of BPA and DES on EZH2 expression and function in MCF-7 cells and in mammary glands of mice exposed in utero. DES and BPA treatment approximated human exposure. EZH2 functional activity was assessed by measuring histone H3 trimethylation. Treatment of MCF-7 cells with DES or BPA led to a 3- and 2-fold increase in EZH2 mRNA expression, respectively (p < 0.05) as well as increased EZH2 protein expression. Mice exposed to DES in utero showed a >2-fold increase in EZH2 expression in adult mammary tissue compared with controls (p < 0.05). EZH2 protein was elevated in mammary tissue of mice exposed to DES or BPA. Histone H3 trimethylation was increased in MCF-7 cells treated with BPA or DES. Similarly, mice exposed to BPA or DES in utero showed increased mammary histone H3 trimethylation. Developmental programming of EZH2 is a novel mechanism by which in utero exposure to endocrine disruptors leads to epigenetic regulation of the mammary gland.

Sources: NCBI, 2010 Jun;1(3):146-55. doi: 10.1007/s12672-010-0015-9.
PMID: 21761357 PubMed PMCID: PMC3140020

Full Article:

In Utero Exposure to Diethylstilbestrol (DES) or Bisphenol-A (BPA) Increases EZH2 Expression in the Mammary Gland: An Epigenetic Mechanism Linking Endocrine Disruptors to Breast Cancer
PMC3140020 2011 July 20.

Related post: Endocrine Disruptors and the Breast: early Life Effects and later Life Disease, NCBI, June 2013

Our posts tagged DES and NCBI – also on Diethylstilbestrol DES on Facebook , Diethylstilbestrol DES Google+ Page icon , Diethylstilbestrol DES on Twitter icon , Diethylstilbestrol DES on Flickr icon , Diethylstilbestrol DES on Pinterest icon , Diethylstilbestrol DES on YouTube icon , Diethylstilbestrol, Journal of a DES Daughter logo

More about BPA – Pesticides – Phthalates

Leave a comment

2 Comments

  1. eavdailytips

     /  26/12/2013

    Thanks Dom
    Oncle Gerrit

    Reply

Please leave a Comment

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Follow

Get every new post delivered to your Inbox.

Join 490 other followers

%d bloggers like this: